Steven Cohen Global Blood Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $13.5 Million - $22.6 Million	604,285 Added 65.67%	1,524,485 $48.7 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $18.9 Million - $26.2 Million	736,729 Added 401.55%	920,200 $31.9 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $53 Million - $85.7 Million	-2,129,129 Reduced 92.07%	183,471 $5.37 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $6.4 Million - $9.37 Million	251,000 Added 12.18%	2,312,600 $58.9 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $23.9 Million - $32 Million	736,118 Added 55.54%	2,061,600 $72.2 Million
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $49.6 Million - $64.7 Million	1,272,802 Added 2416.1%	1,325,482 $54 Million
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $6.08 Million - $10.3 Million	-161,433 Reduced 75.4%	52,680 $2.28 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $3.57 Million - $6 Million	-73,304 Reduced 25.5%	214,113 $13.5 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $7.4 Million - $15.5 Million	-177,264 Reduced 38.15%	287,417 $14.7 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $11.1 Million - $19.9 Million	-243,127 Reduced 34.35%	464,681 $36.9 Million
Q3 2019 Nov 15, 2019	BUY	$45.35 - $57.91 $32.1 Million - $41 Million	707,808 New	707,808 $34.3 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $16.6 Million - $22.3 Million	-435,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $8.11 Million - $10.5 Million	209,600 Added 92.62%	435,900 $19.7 Million
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $53.4 Million - $82.1 Million	-1,796,400 Reduced 88.81%	226,300 $8.91 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $50.8 Million - $62.8 Million	2,022,700	2,022,700 $62.8 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account